These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 38958986)
1. The correlation between TRIM28 expression and immune checkpoints in CRPC. Xue D; Zuo Q; Chang J; Wu X FASEB J; 2024 Jul; 38(13):e23663. PubMed ID: 38958986 [TBL] [Abstract][Full Text] [Related]
2. JMJD2A promotes the development of castration-resistant prostate cancer by activating androgen receptor enhancer and inhibiting the cGAS-STING pathway. Cai X; Yu X; Tang T; Xu Y; Wu T Mol Carcinog; 2024 Sep; 63(9):1682-1696. PubMed ID: 38818897 [TBL] [Abstract][Full Text] [Related]
3. Silencing HOXC13 exerts anti-prostate cancer effects by inducing DNA damage and activating cGAS/STING/IRF3 pathway. Li M; Bai G; Cen Y; Xie Q; Chen J; Chen J; Chen Q; Zhong W; Zhou X J Transl Med; 2023 Dec; 21(1):884. PubMed ID: 38057852 [TBL] [Abstract][Full Text] [Related]
4. The SETDB1-TRIM28 Complex Suppresses Antitumor Immunity. Lin J; Guo D; Liu H; Zhou W; Wang C; Müller I; Kossenkov AV; Drapkin R; Bitler BG; Helin K; Zhang R Cancer Immunol Res; 2021 Dec; 9(12):1413-1424. PubMed ID: 34848497 [TBL] [Abstract][Full Text] [Related]
5. Patient-derived Hormone-naive Prostate Cancer Xenograft Models Reveal Growth Factor Receptor Bound Protein 10 as an Androgen Receptor-repressed Gene Driving the Development of Castration-resistant Prostate Cancer. Hao J; Ci X; Xue H; Wu R; Dong X; Choi SYC; He H; Wang Y; Zhang F; Qu S; Zhang F; Haegert AM; Gout PW; Zoubeidi A; Collins C; Gleave ME; Lin D; Wang Y Eur Urol; 2018 Jun; 73(6):949-960. PubMed ID: 29544736 [TBL] [Abstract][Full Text] [Related]
6. E3 ligase TRIM28 promotes anti-PD-1 resistance in non-small cell lung cancer by enhancing the recruitment of myeloid-derived suppressor cells. Liang M; Sun Z; Chen X; Wang L; Wang H; Qin L; Zhao W; Geng B J Exp Clin Cancer Res; 2023 Oct; 42(1):275. PubMed ID: 37865804 [TBL] [Abstract][Full Text] [Related]
7. Liu J; Han X; Chen L; Han D; Mu X; Hu X; Wu H; Wu H; Liu W; Zhao Y Aging (Albany NY); 2020 Oct; 12(20):20308-20331. PubMed ID: 33091876 [TBL] [Abstract][Full Text] [Related]
8. RIPK3 activation induces TRIM28 derepression in cancer cells and enhances the anti-tumor microenvironment. Park HH; Kim HR; Park SY; Hwang SM; Hong SM; Park S; Kang HC; Morgan MJ; Cha JH; Lee D; Roe JS; Kim YS Mol Cancer; 2021 Aug; 20(1):107. PubMed ID: 34419074 [TBL] [Abstract][Full Text] [Related]
9. Effect of dietary omega-3 fatty acids on castrate-resistant prostate cancer and tumor-associated macrophages. Liang P; Henning SM; Guan J; Grogan T; Elashoff D; Cohen P; Aronson WJ Prostate Cancer Prostatic Dis; 2020 Mar; 23(1):127-135. PubMed ID: 31439889 [TBL] [Abstract][Full Text] [Related]
10. GATA2 promotes castration-resistant prostate cancer development by suppressing IFN-β axis-mediated antitumor immunity. Jin Z; Wang H; Tang R; Pan B; Lee HJ; Liu S; Wang L; Qin J; Xu M Oncogene; 2024 Aug; 43(34):2595-2610. PubMed ID: 39068217 [TBL] [Abstract][Full Text] [Related]
11. Carbon ion irradiation exerts antitumor activity by inducing cGAS-STING activation and immune response in prostate cancer-bearing mice. Hu W; Zhang Z; Xue Y; Ning R; Guo X; Sun Y; Zhang Q Cancer Med; 2024 Jan; 13(2):e6950. PubMed ID: 38379323 [TBL] [Abstract][Full Text] [Related]
12. Radiation Therapy Promotes Hepatocellular Carcinoma Immune Cloaking via PD-L1 Upregulation Induced by cGAS-STING Activation. Du SS; Chen GW; Yang P; Chen YX; Hu Y; Zhao QQ; Zhang Y; Liu R; Zheng DX; Zhou J; Fan J; Zeng ZC Int J Radiat Oncol Biol Phys; 2022 Apr; 112(5):1243-1255. PubMed ID: 34986380 [TBL] [Abstract][Full Text] [Related]
13. Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy. Lv M; Chen M; Zhang R; Zhang W; Wang C; Zhang Y; Wei X; Guan Y; Liu J; Feng K; Jing M; Wang X; Liu YC; Mei Q; Han W; Jiang Z Cell Res; 2020 Nov; 30(11):966-979. PubMed ID: 32839553 [TBL] [Abstract][Full Text] [Related]
14. Anti-androgen therapy induces transcriptomic reprogramming in metastatic castration-resistant prostate cancer in a murine model. Zhao Y; Peng X; Baldwin H; Zhang C; Liu Z; Lu X Biochim Biophys Acta Mol Basis Dis; 2021 Jul; 1867(7):166151. PubMed ID: 33892077 [TBL] [Abstract][Full Text] [Related]
15. Mitochondrial (mt)DNA-cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) signaling promotes pyroptosis of macrophages via interferon regulatory factor (IRF)7/IRF3 activation to aggravate lung injury during severe acute pancreatitis. Peng Y; Yang Y; Li Y; Shi T; Xu N; Liu R; Luan Y; Yao Y; Yin C Cell Mol Biol Lett; 2024 Apr; 29(1):61. PubMed ID: 38671352 [TBL] [Abstract][Full Text] [Related]
16. Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer. Yang KS; Xu CQ; Lv J Bioengineered; 2021 Dec; 12(1):1238-1250. PubMed ID: 33843442 [TBL] [Abstract][Full Text] [Related]
17. Arginine starvation elicits chromatin leakage and cGAS-STING activation via epigenetic silencing of metabolic and DNA-repair genes. Hsu SC; Chen CL; Cheng ML; Chu CY; Changou CA; Yu YL; Yeh SD; Kuo TC; Kuo CC; Chuu CP; Li CF; Wang LH; Chen HW; Yen Y; Ann DK; Wang HJ; Kung HJ Theranostics; 2021; 11(15):7527-7545. PubMed ID: 34158865 [No Abstract] [Full Text] [Related]
18. Alterations of tumor microenvironment by nitric oxide impedes castration-resistant prostate cancer growth. Arora H; Panara K; Kuchakulla M; Kulandavelu S; Burnstein KL; Schally AV; Hare JM; Ramasamy R Proc Natl Acad Sci U S A; 2018 Oct; 115(44):11298-11303. PubMed ID: 30322928 [TBL] [Abstract][Full Text] [Related]
19. Intratumoral delivery of the chitin-derived C100 adjuvant promotes robust STING, IFNAR, and CD8 Turley JL; Ward RW; Huete-Carrasco J; Muñoz-Wolf N; Roche K; Jin L; Bowie A; Andersson M; Lavelle EC Cell Rep Med; 2024 May; 5(5):101560. PubMed ID: 38729159 [TBL] [Abstract][Full Text] [Related]
20. Targeting KDM4B that coactivates c-Myc-regulated metabolism to suppress tumor growth in castration-resistant prostate cancer. Wu MJ; Chen CJ; Lin TY; Liu YY; Tseng LL; Cheng ML; Chuu CP; Tsai HK; Kuo WL; Kung HJ; Wang WC Theranostics; 2021; 11(16):7779-7796. PubMed ID: 34335964 [No Abstract] [Full Text] [Related] [Next] [New Search]